bluebird bio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.33
|
|
Average Rating
|
2.82
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
8
|
|
# Sells
|
1
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.12
|
-0.94
|
0.18
|
16.07%
|
|
2022-06-30
|
-1.24
|
-1.36
|
-0.12
|
-9.68%
|
|
2022-03-31
|
-1.39
|
-1.66
|
-0.27
|
-19.42%
|
|
2021-12-31
|
-1.88
|
-2.14
|
-0.26
|
-13.83%
|
|
2021-09-30
|
-2.59
|
-3.16
|
-0.57
|
-22.01%
|
|
2021-06-30
|
-3.25
|
-3.58
|
-0.33
|
-10.15%
|
|
2021-03-31
|
-3.01
|
-3.07
|
-0.06
|
-1.99%
|
|
2020-12-31
|
-2.92
|
-3.01
|
-0.09
|
-3.08%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.96
|
|
2021-12-31
|
-11.95
|
|
2020-12-31
|
-9.95
|
|
2019-12-31
|
-14.31
|
|
2018-12-31
|
-10.67
|
|
2017-12-31
|
-7.66
|
|
2016-12-31
|
-7.06
|
|
2015-12-31
|
-4.80
|
|
2014-12-31
|
-2.26
|
|
2013-12-31
|
-2.73
|